NDC 42192-327 – NP Thyroid 15
Liothyronine 2.25 ug/1; Levothyroxine 9.5 ug/1 · Tablet · Oral
Product NDC42192-327
Product details
- Brand name
- NP Thyroid 15
- Generic name
- Levothyroxine, Liothyronine
- Labeler
- Acella Pharmaceuticals, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketed since
- November 16, 2016
- Listing expires
- December 31, 2027
- Pharmacologic class
- l-Thyroxine; l-Triiodothyronine
Active ingredients
- Liothyronine 2.25 ug/1
- Levothyroxine 9.5 ug/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 42192-327-01 | 100 TABLET in 1 BOTTLE (42192-327-01) | Nov 16, 2016 |
| 42192-327-30 | 30 TABLET in 1 BOTTLE (42192-327-30) | Mar 3, 2025 |
| 42192-327-90 | 90 TABLET in 1 BOTTLE (42192-327-90) | Dec 1, 2025 |
Recalls mentioning this NDC
- D-0396-2021 Jun 2, 2021 · Class I
Subpotent Drug - D-0397-2021 Jun 2, 2021 · Class I
Subpotent Drug - D-0399-2021 Jun 2, 2021 · Class I
Subpotent Drug - D-0398-2021 Jun 2, 2021 · Class I
Subpotent Drug - D-0395-2021 Jun 2, 2021 · Class I
Subpotent Drug - D-0035-2021 Oct 28, 2020 · Class I
Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product. - D-0036-2021 Oct 28, 2020 · Class I
Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product. - D-1299-2020 Jun 10, 2020 · Class I
Superpotent Drug. - D-1298-2020 Jun 10, 2020 · Class I
Superpotent Drug. - D-1300-2020 Jun 10, 2020 · Class I
Superpotent Drug.
Other NP Thyroid 15 products
- 76420-566 Levothyroxine 9.5 ug/1; Liothyronine 2.25 ug/1 · Tablet · Asclemed USA, Inc.
- 63629-8265 Levothyroxine 9.5 ug/1; Liothyronine 2.25 ug/1 · Tablet · Bryant Ranch Prepack